Investor profile
R42 Group has backed 11 European tech companies across 12 funding rounds between 2021 and 2026, joining rounds totalling €85M. Most active in Healthtech and Energy. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| €3.5M |
| ExSeed Health | UK | 1 | €2.9M |
| Spirea | UK | 1 | €2.9M |
| Oxford Drug Design | UK | 1 | €2.6M |
| Silveray | UK | 1 | €2.5M |
| WiseWorks AI | UK | 1 | €1.1M |
| Stamp Free | UK | 1 | €708k |
| €4.1M |
| 2022-10 |
| ExSeed Health | Seed | €2.9M | 2022-02 |
| Spirea | Other | €2.9M | 2022-06 |
| Oxford Drug Design | Other | €2.6M | 2022-05 |
| Silveray | Seed | €2.5M | 2022-10 |
| xWatts | Seed | €1.8M | 2026-02 |
| xWatts | Other | €1.6M | 2024-07 |
